AstraZeneca Becomes the IBA’s Newest Corporate Partner

The IBA is excited to welcome AstraZeneca as its newest Corporate Partner. AstraZeneca is a global, innovation-driven bio-pharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

Through its Supplier Diversity office at its North American headquarters in Wilmington Delaware, AstraZeneca will be working with the IBA to enhance its supplier network of LGBT businesses. The IBA looks forward to connecting AstraZeneca with our many successful business members. Stay tuned for more exciting news in the coming year about opportunities to showcase your business to AstraZeneca.

Welcome aboard AstraZeneca!